News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Bank of Russia cuts key rate 25 bps to 14.25%, signaling cautious easing despite fuel-production disruptions and looser fiscal plans.
  • RBI minutes show unanimous hold at a 5.25% repo rate and a neutral stance amid oil, rupee, and weather risks to inflation.
  • Sterling steadies above $1.32 after stronger retail sales, but political strain leaves the pound near two-month lows.
  • Cognizant (CTSH) flagged as a tactical long after shares fell near 52-week lows, citing strong free cash flow and high short interest.
  • DHI Group (DHX) touted as an opportunistic long for its cash-generation and low valuation with defined stop and target levels.
  • Lite Strategy will speak at the Litecoin Foundation Summit, underscoring institutional adoption after adopting Litecoin as its primary treasury asset.
  • West Bancorporation schedules Q2 results and a July 23 conference call, adding to regional-bank earnings flow.

Latest Articles

BrewDog USA Brings Summer Soccer to Life with Watch Parties and Fan Events in Las Vegas and Across Ohio

BrewDog USA Brings Summer Soccer to Life with Watch Parties and Fan Events in Las Vegas and Across Ohio

Tilray Brands’ BrewDog USA division is hosting a series of summer soccer programming events across its U.S. bars, including flagship locations in Las Vegas and Ohio. The initiative features live match screenings, special promotions on beer and food, and fan engagement activities aimed at cultivating a lively community atmosphere during the global s…

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease

Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease

Acumen Pharmaceuticals announced the nomination of two novel development candidates under its Enhanced Brain Delivery program for Alzheimer's disease treatment. Utilizing a blood-brain barrier-penetrating technology licensed from JCR Pharmaceuticals, the candidates combine Acumen's amyloid beta oligomer-selective antibodies with JCR's J-Brain Cargo…

Nexxen Raises Full-Year 2026 Contribution ex-TAC and Programmatic Revenue Guidance for the Second Time This Year Ahead of Today’s Investor Day

Nexxen Raises Full-Year 2026 Contribution ex-TAC and Programmatic Revenue Guidance for the Second Time This Year Ahead of Today’s Investor Day

Nexxen International Ltd. has updated its full-year 2026 financial guidance, increasing its contribution ex-TAC and programmatic revenue estimates for the second time this year. The company projects 11% growth in contribution ex-TAC and 13% growth in programmatic revenue year-over-year, driven by strong growth in Connected TV (CTV) and mobile reven…

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical

FocalTherics has entered into an agreement with MellingMedical to provide its Focal One Robotic HIFU prostate cancer treatment technology to veterans and active-duty military personnel through the Veterans Healthcare System and Department of Defense healthcare systems. This non-invasive treatment option aims to improve prostate cancer care while pr…

Keep Adding WES: High Yield, Real Cash Flow, and Room to Run

Keep Adding WES: High Yield, Real Cash Flow, and Room to Run

Western Midstream (WES) offers a compelling income trade: an 8%+ distribution, $1.34B of free cash flow and an EV/EBITDA of ~11.1. Technicals are neutral, fundamentals show healthy coverage and scale, and near-term catalysts (MLP flows, produced-water growth, steady gas volumes) support upside. Recommendation: add at $44.00, stop $40.50, target $49…

FBI Says It Disrupted Alleged Plot Targeting UFC Event in Washington

FBI Says It Disrupted Alleged Plot Targeting UFC Event in Washington

The FBI announced it had disrupted a potential threat connected to the Ultimate Fighting Championship event in Washington, D.C., saying multiple people are in custody following a multistate operation. An external report cited unnamed sources alleging the plan involved explosive-laden drones aimed at buildings near the event. The bureau said it beca…

Rackspace Shares Jump After Deal to Deploy 30 MW of AMD AI Compute

Rackspace Shares Jump After Deal to Deploy 30 MW of AMD AI Compute

Rackspace Technology shares surged after the company finalized an agreement with AMD to deploy 30 MW of AMD-based AI compute hardware across its global data centers. The pact, which implements a May 7, 2026 memorandum of understanding, names AMD a strategic technology partner for Rackspace's governed AI stack and outlines a phased rollout beginning…

Citi Trims Gas Price Outlook as Middle East Tensions Ease

Citi Trims Gas Price Outlook as Middle East Tensions Ease

Citi has pared back its natural gas price projections after a market selloff and expects further downward pressure as geopolitical frictions in the Middle East subside. The bank pointed to a 15% to 20% drop in TTF and JKM from intraday highs on June 11, soft Asian LNG imports, robust Chinese hydroelectric output, increased water flows in Southeast …

Mobileye to Build Own Robotaxi Service, Eyes Major Fleet Scale-Up

Mobileye to Build Own Robotaxi Service, Eyes Major Fleet Scale-Up

Mobileye shares climbed 5% after the company unveiled plans to launch a vertically integrated robotaxi operation. The plan calls for about 100 fully driverless vehicles to begin phased service in a U.S. metropolitan area in 2027 with a target to grow to roughly 17,000 vehicles within five years, while continuing to supply its Mobileye Drive system …

Trump Says Interim Iran Accord Makes Clear Tehran Will Not Obtain Nuclear Weapons

Trump Says Interim Iran Accord Makes Clear Tehran Will Not Obtain Nuclear Weapons

At the G7 summit in Evian-les-Bains, U.S. President Donald Trump defended an unpublished 14-point interim memorandum with Iran, insisting it explicitly prevents Tehran from acquiring a nuclear weapon. He warned of severe consequences if Iran pursues such a capability and previewed detailed negotiations scheduled to begin in Switzerland, while raisi…

Evenly Divided Andean District Reflects Peru’s Deep Political Fault Lines

Evenly Divided Andean District Reflects Peru’s Deep Political Fault Lines

In the mountain district of Lahuaytambo, 181 votes for Keiko Fujimori and 181 for Roberto Sanchez during the June 7 presidential runoff present a stark local reflection of a nationally tight and polarized race. The tie illustrates persistent rural-urban divides, widespread distrust of political elites and competing local priorities that center on i…

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Invivyd, Inc. announced completion of enrollment for their Phase 3 LIBERTY clinical trial evaluating the safety, tolerability, and immune response of their investigational COVID-19 monoclonal antibody VYD2311 compared to mRNA COVID-19 vaccines, including co-administration effects. The trial is part of Invivyd's broader REVOLUTION clinical program t…

SpaceX to Buy Cursor Creator Anysphere in $60 Billion All-Stock Deal

SpaceX to Buy Cursor Creator Anysphere in $60 Billion All-Stock Deal

SpaceX announced it will acquire Anysphere, the developer of the AI coding tool Cursor, in an all-stock transaction valuing the software company at $60 billion. The deal, signed June 16, 2026, calls for a merger between SpaceX subsidiary X67 Inc. and Cursor and is expected to close in the third quarter of 2026. Cursor shareholders will receive Spac…

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge Biosciences announced that the FDA has granted Fast Track Designation to givastomig, a novel bispecific antibody, combined with nivolumab and chemotherapy for treating patients with previously untreated HER2-negative advanced or metastatic gastroesophageal adenocarcinomas. This designation is expected to accelerate the development and re…